Further investigations are required to develop a novel vaccine or therapeutic method against BLV infection, perhaps using anti-Tim-3 antibodies or a recombinant Tim-3 Fc fusion protein. The gene discussed is HAVCR2; the disease is deltaretrovirus infections.